Eastman Chemical experienced a 19.84% decrease in insider ownership, with 18,021 shares sold valued at nearly $1.9 million in the last ninety days. Institutional investors hold 83.65% of the stock, while analysts maintain a "Moderate Buy" rating, with an average target price of $112.54. Recent trading saw shares rise 7.4%, closing at $99.53, following a positive earnings report that exceeded expectations.